A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2004
11/10/2004	CN1544035A Medicine for treating dyspepsia and fever of children
11/10/2004	CN1544034A Songqi traumatic injury treating ointment
11/10/2004	CN1544033A Freeze-dried powder injection of Qingkailing and its preparation process
11/10/2004	CN1544031A Oral liquid of Jiuwei Qianghuo and its preparation process
11/10/2004	CN1544030A Huanglian Shangqing Granule and preparation method thereof
11/10/2004	CN1544007A Novel olive kernel leaf extracts and preparation process and medical use thereof
11/10/2004	CN1543991A Cold dispelling and pain alleviating liquid and its preparation and operation guide
11/10/2004	CN1543963A Use of 2ª‡,23-dihydroxyl ursolic acid in preparing the anti-inflammatory agent
11/10/2004	CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof
11/10/2004	CN1543930A Method for making plaster adhesive bandage
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174770C External medicine for curing gynaecological inflammation and its preparing method
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815464 Halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate derivatives; analgesics
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6815443 5-Amino-1-pentene-3-ol substituted derivatives
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815214 Pharmaceutical uses and synthesis of diketopiperazines
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/09/2004	US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094432A1 Porphyrin compound containing biotinyl group and use thereof
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094379A2 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004093912A1 Preventive and/or therapeutic agent for neutrophil inflammation disease
11/04/2004	WO2004093897A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004080951A3 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/04/2004	WO2004069792A8 Quinoline-derived amide modulators of vanilloid vr1 receptor
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220411 Oxalic acid derivatives
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220247 N-[4-(4,5-Dihydro-1H-imidazol-2-yl-amino)-benzyl]-4-methoxy-benzamide and derivatives; prostaglandin inhibitors; urinary tract disease, disease related pain, neuropathic pain, respiratory asthma, allergy
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220241 Substituted biphenyl derivatives
11/04/2004	US20040220234 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220208 Imidazopyridinones as p38 map kinase inhibitors
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220111 administering polypeptide in mixturte with carrier; topical applying surface of body; wound healing agents; tissue repair
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219597 Using cytokeratin marker peptides as diagnostic, prognostic and treatment tools for inflammations and/or infections in animals or humans; sepsis prevention; veterinary medicine
11/04/2004	US20040219573 Screening method using BNPI and DNPI
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219220 Therapeutic agents
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219172 In situ administering botulinum toxins
11/04/2004	US20040219150 Uses of mammalian cytokine; related reagents
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219145 Compositions and methods to modulate immune and inflammatory responses
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	CA2823468A1 Compositions and methods for the therapy of inflammatory bowel disease
11/04/2004	CA2746531A1 Non-steroidal anti-inflammatory drug dosing regimen
11/04/2004	CA2520655A1 Compositions for mucosal and oral administration comprising hcg fragments
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473300A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472357A2 Elongase gene and method for producing polyunsaturated fatty acids
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472272A1 Crystalline complexes of fluticasone 2-furoate
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion

1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 1272